Rajvi Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.07 M
- Revenue Growth 1.63%
- Profit Growth 12.42%
- Ebitda -2.61%
- Net Worth 11.12%
- Total Assets -9.61%
About Rajvi Biotech
Rajvi Biotech Private Limited (RBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 April 2007 and has a history of 17 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company has closed loans amounting to ₹1.07 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nikunjkumar Modi, Nehalben Modi, Hasumatiben Modi, and One other member serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24233GJ2007PTC050664
- Company No.
050664
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Rajvi Biotech?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikunjkumar Modi  | Director | 18-Jan-2010 | Current |
| Nehalben Modi | Director | 26-Apr-2007 | Current |
| Hasumatiben Modi | Director | 05-Dec-2018 | Current |
| Mahendrabhai Kantilal | Director | 26-Apr-2007 | Current |
Financial Performance of Rajvi Biotech.
Rajvi Biotech Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.63% increase. The company also saw a substantial improvement in profitability, with a 12.42% increase in profit. The company's net worth Soared by an impressive increase of 11.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rajvi Biotech?
In 2019, Rajvi Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bhavani Pharmachem Private LimitedNikunjkumar Modi, Nehalben Modi and 2 more are mutual person
Harsh Biotech Private LimitedNikunjkumar Modi, Nehalben Modi and 2 more are mutual person
- Bhavani Medilink Private Limited
Nikunjkumar Modi, Nehalben Modi and 2 more are mutual person
Charges (Loans)
₹0
₹1.07 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2018 | Bank Of India | ₹0.62 M | Satisfied |
| 13 Jun 2009 | Bank Of India | ₹0.45 M | Satisfied |
How Many Employees Work at Rajvi Biotech?
Unlock and access historical data on people associated with Rajvi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajvi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajvi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
